The query is not regardless of whether retatrutide is effective -- the info is powerful -- but just how long the regulatory route can take and if the acceptance lands with a security profile that insurers and clients can perform with.We have seen all these. One vendor we examined in late 2024 was promoting "retatrutide" that turned out to get BPC-1